Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Bridoux

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 19, 2013
C3 glomerulopathy in adults: monoclonal gammopathy should be consideredGuy Touchard, Frank Bridoux
La Revue Du Praticien|May 27, 2014
[Amyloidosis]Arnaud Jaccard, Frank Bridoux
Nephrologie & Therapeutique|April 15, 2019
Treatment of AL amyloidosisArnaud Jaccard, Frank Bridoux
Kidney International|October 1, 2014
Mesangial cells as amyloid factory: a unique contribution of animal modelsChristophe Sirac, Frank Bridoux
Advances in Chronic Kidney Disease|August 28, 2012
Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trialFrank Bridoux, Jean-Paul Fermand
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Renal impairment in multiple myeloma: time is of the essenceColin A Hutchison, Frank Bridoux
Kidney International|March 22, 2024
Autosomal dominant chronic tubulointerstitial nephropathy: do not forget amyloidosisFrank Bridoux, Samih H Nasr
Nephrologie & Therapeutique|August 10, 2006
[Glomerulonephritis with organized immunoglobulin deposits]Guy Touchard, Frank Bridoux, Jean-Michel Goujon
Kidney International|April 24, 2022
The authors replyFrank Bridoux, Nelson Leung, Jean Paul Fermand
The Lancet. Haematology|June 28, 2019
High cutoff haemodialysis in myeloma cast nephropathy: further investigation is neededFrank Bridoux, Sylvie Chevret, Jean-Paul Fermand
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 19, 2013
C3 glomerulopathy in adults: monoclonal gammopathy should be consideredGuy Touchard, Frank Bridoux
La Revue Du Praticien|May 27, 2014
[Amyloidosis]Arnaud Jaccard, Frank Bridoux
Nephrologie & Therapeutique|April 15, 2019
Treatment of AL amyloidosisArnaud Jaccard, Frank Bridoux
Kidney International|October 1, 2014
Mesangial cells as amyloid factory: a unique contribution of animal modelsChristophe Sirac, Frank Bridoux
Advances in Chronic Kidney Disease|August 28, 2012
Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trialFrank Bridoux, Jean-Paul Fermand
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Renal impairment in multiple myeloma: time is of the essenceColin A Hutchison, Frank Bridoux
Kidney International|March 22, 2024
Autosomal dominant chronic tubulointerstitial nephropathy: do not forget amyloidosisFrank Bridoux, Samih H Nasr
Nephrologie & Therapeutique|August 10, 2006
[Glomerulonephritis with organized immunoglobulin deposits]Guy Touchard, Frank Bridoux, Jean-Michel Goujon
Kidney International|April 24, 2022
The authors replyFrank Bridoux, Nelson Leung, Jean Paul Fermand
The Lancet. Haematology|June 28, 2019
High cutoff haemodialysis in myeloma cast nephropathy: further investigation is neededFrank Bridoux, Sylvie Chevret, Jean-Paul Fermand
Pageof 17